Syra Health Corp
Syra Health Corp
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 0 | |||||
Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 1 | - | 1 | - | - | - | - | 1 | |||||
Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 4 | 3 | 4 | 5 | 1 | |||||
Deferred Costs | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 4 | 4 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 5 | 5 | 3 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | - | - | - | - | 1 | 0 | 0 | 0 | 1 | 1 | 0 | - | |||||
Liabilities Current | |||||||||||||||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Revenue Current | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | - | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Lines Of Credit Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Liabilities Current | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
Operating Lease Liability Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | - | - | - | |||||
Liabilities | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | |||||
Stockholders Equity | |||||||||||||||||
Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Additional Paid In Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 10 | 10 | 9 | 3 | |||||
Retained Earnings Accumulated Deficit | -9 | -9 | -10 | -10 | -9 | -9 | -9 | -8 | -8 | -7 | -5 | -4 | |||||
Stockholders Equity | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 4 | -1 | |||||
Liabilities And Stockholders Equity | 4 | 4 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 5 | 5 | 3 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 10.00% | 8.00% | 34.00% | - | - | - | - | - | - | - | - | - |
| 2025 | -11.46% | 4.17% | 4.17% | 20.00% | 12.00% | 1.33% | 2.99% | 29.85% | 19.40% | 127.62% | 357.14% | 423.81% |
| 2024 | -7.95% | -9.27% | -20.66% | -20.61% | -69.24% | -69.16% | -25.31% | -22.45% | 0.00% | -46.29% | -70.00% | -75.71% |
| 2023 | - | - | - | - | - | - | 6.72% | -17.97% | -11.72% | -31.33% | 6.00% | -0.67% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.13 | 2.48 | 4.06 | 3.05 | 3.25 | 2.88 | 5.46 | 4.63 | 3.14 | 4.04 | 5.25 | 0.52 | |||||
| Quick Ratio | 3.13 | 2.48 | 4.06 | 3.05 | 3.25 | 2.88 | 5.46 | 4.63 | 3.14 | 4.04 | 5.25 | 0.52 | |||||
| Working Capital | 2.55M | 2.35M | 2.06M | 2.16M | 2.38M | 2.38M | 2.74M | 3.19M | 1.93M | 3.35M | 3.87M | -1.14M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.45 | 0.67 | 0.32 | 0.48 | 0.44 | 0.52 | 0.28 | 0.33 | 0.55 | 0.32 | 0.23 | -3.12 | |||||
| Interest Coverage TTM | 6.88 | -19.20 | -68.15 | -87.49 | -98.59 | -189.42 | -241.34 | -117.14 | -93.05 | - | - | - | |||||
| Debt Ratio | 0.31 | 0.40 | 0.24 | 0.32 | 0.30 | 0.34 | 0.22 | 0.25 | 0.35 | 0.24 | 0.18 | 1.47 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 2.22 | 1.99 | 2.24 | 1.95 | 2.40 | 1.95 | 1.86 | 2.82 | 2.85 | - | - | - | |||||
| Days Sales Outstanding TTM | 53.16 | 41.51 | 40.39 | 45.09 | 40.12 | - | 31.13 | - | - | - | - | - | |||||
| Receivables Turnover TTM | 6.87 | 8.79 | 9.04 | 8.10 | 9.10 | - | 11.72 | - | - | - | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.01 | -0.01 | -0.08 | -0.11 | -0.12 | -0.24 | -0.50 | -0.80 | -0.87 | - | - | - | |||||
| Free Cash Flow Per Share TTM | -0.08 | 0.06 | -0.04 | -0.04 | -0.06 | -0.17 | -0.39 | -0.62 | -0.77 | - | - | - | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 39.35% | 37.56% | 34.43% | 29.76% | 29.08% | 24.02% | 20.71% | 21.95% | 22.32% | - | - | - | |||||
| Operating Profit Margin TTM | 0.92% | -3.14% | -12.51% | -16.94% | -18.19% | -34.55% | -47.17% | -58.61% | -61.94% | - | - | - | |||||
| Net Profit Margin TTM | 1.62% | -2.40% | -12.40% | -16.89% | -18.08% | -34.43% | -47.10% | -58.92% | -62.53% | - | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 0.32% | -5.51% | -9.47% | -24.33% | -12.70% | - | - | - | - | - | - | - | |||||
| Net Income Growth (1Y) | -108.97% | -93.42% | -76.16% | -78.31% | -74.76% | - | - | - | - | - | - | - | |||||
| EPS Growth (1Y) | -108.13% | -93.62% | -84.81% | -86.80% | -86.04% | - | - | - | - | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 64.29 | -14.02 | -1.14 | -0.85 | -0.89 | -1.08 | -0.83 | -0.53 | -1.57 | - | - | - | |||||
| P/B TTM | 3.19 | 1.09 | 0.49 | 0.49 | 0.54 | 1.23 | 1.08 | 0.92 | 4.32 | 2.60 | 1.23 | -10.64 | |||||
| P/S TTM | 1.04 | 0.34 | 0.14 | 0.14 | 0.16 | 0.37 | 0.39 | 0.31 | 0.98 | - | - | - | |||||
| Market Cap | 8.41M | 2.57M | 1.02M | 1.07M | 1.30M | 3.01M | 3.11M | 3.08M | 9.05M | 8.96M | 4.96M | 13.08M | |||||
| Enterprise Value | 6.35M | -293.37K | -479.05K | -713.12K | -917.84K | 597.09K | 868.73K | 623.02K | 7.57M | 5.82M | 1.86M | 14.82M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -1.09M | 755.97K | -447.75K | -531.51K | -700.50K | -1.98M | -2.94M | -4.49M | -5.09M | - | - | - | |||||
| Net Debt | -2.05M | -2.86M | -1.50M | -1.79M | -2.22M | -2.42M | -2.24M | -2.46M | -1.48M | -3.14M | -3.10M | 1.74M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Syra Health Corp (SYRA) — SEC Financial Statements & Analysis
Syra Health Corp (SYRA) is a services-employment agencies company, incorporated in DE. Syra Health Corp trades on OTC as: SYRA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Syra Health Corp reported a 0.32% year-over-year revenue growth, a Gross Profit Margin of 39.35% (TTM), a Debt-to-Equity ratio of 0.45x, a Price-to-Sales (P/S) ratio of 1.04x (TTM), a Price-to-Book (P/B) ratio of 3.19x (TTM), at a market cap of $8.41M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 0.32%
- Gross Profit Margin TTM
- 39.35%
- Debt To Equity
- 0.45x
- P/S TTM
- 1.04x
- P/B TTM
- 3.19x
- Market Cap
- $8.41M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Syra Health Corp in?
Syra Health Corp (SYRA) operates in the Services-Employment Agencies industry.
What is SYRA's market cap?
Syra Health Corp (SYRA) has a market capitalization of $8.41M as of 2026-06-30.
What is SYRA's P/E ratio?
Syra Health Corp (SYRA)'s trailing twelve month P/E ratio is 64.29x as of 2026-06-30.
What exchange does SYRA trade on?
Syra Health Corp (SYRA) trades on the OTC.
Where is Syra Health Corp incorporated?
Syra Health Corp is incorporated in DE.